We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Mylan Says Cephalon’s IP Win Based On Wrong Construction

Law360, Los Angeles (August 26, 2013, 9:09 PM EDT) -- Mylan Pharmaceuticals Inc. on Friday urged the Federal Circuit to reverse a district court's ruling that it infringed three patents for Cephalon Inc.'s cancer painkiller Fentora, saying the lower court failed to use...
To view the full article, register now.